{"task_id": "22598da5f323d847", "source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 430/464)", "text": "monary Surgery and Postoperative Complications\n423\n\n--- Page 445 ---\n\u0003 CXR\nshould be obtained if age >60 or sus\npect/known lung pathologies\n\u0003\nPULMONARY\nFUNCTION\nTESTS\npatients under\ngoing thoracic or upper abdominal surgery\nwith unexplained dyspnea and for those with\nCOPD or asthma where clinical evaluation can\nnot determine if airflow obstruction has been\noptimally reduced\n\u0003\nLUNG\nRESECTION\nWORKUP\npatients with pre\noperative FEV1 >2 L can probably tolerate pneu\nmonectomy. Patients with FEV1 <2 L but pre\ndicted postoperative FEV1 >800 mL can probably\ntolerate lung resection. DLCO <40% suggests\nhigh postoperative risk. Patients with VO2max\n>15 mL/kg/min during cardiopulmonary exercise\ntesting will likely tolerate surgery\nNEJM 1999 340:12\nMANAGEMENT OF PERIOPERATIVE PATIENTS\n1. REASON FOR CONSULT\ndetermine the reason\nfor surgery and try to answer specific questions\nfrom the referring physician. Next, explore the 8\nkey domains of Perioperative assessment\n2. CARDIAC RISK OPTIMIZATION\n\u0003\nOPTIMAL TIMING\nmyocardial infarction (wait\n4 6 weeks if small to moderate MI. Wait >3\nmonths if severe MI or LV dysfunction). Angio\nplasty (see ACC/AHA algorithm for patients with\nprevious PCI). CABG (wait at least 1 month)\n\u0003\nOVERALL ELIGIBILITY\nif no acute MI, acute HF,\nsevere mitral or aortic stenosis, severe arrhyth\nmia will likely be able to go for surgery\n\u0003\nPREOPERATIVE\nb blockers (for Lee score \u00072,\ngive atenolol 10 mg IV over 15 min prior to\nsurgery, then atenolol 50 100 mg PO daily or\nbisoprolol 5 10 mg PO daily, titrate to HR 50 60\nfor a total of 1 month). a2 agonists (clonidine\n0.1 mg PO BID). CABG (indications include poorly\ncontrolled angina despite maximal medical ther\napy, >50% stenosis of left main coronary artery,\n>70% stenosis of 2 or 3 vessel coronary artery\ndisease with involvement of proximal LAD, easily\ninduced myocardial ischemia on preoperative\nstress testing, and left ventricular systolic dys\nfunction). Angioplasty (see ACC/AHA algorithm\nfor patients who require PCI prior to subsequent\nsurgery). Valvular surgery (e.g. symptomatic\naortic stenosis. If indicated should be done\nbefore elective non cardiac surgery. If urgent\nsurgery and severe aortic or mitral stenosis, con\nsider balloon valvuloplasty)\n\u0003\nPOSTOPERATIVE\ndaily\nECG\nand\ntroponin\n\u00023 days if high risk and patient unable to com\nmunicate angina\n3. BACTERIAL ENDOCARDITIS PROPHYLAXIS\nonly given to patients with the highest risk of devel\noping endocarditis, which include the following\n\u0003\nHIGH-RISK CARDIAC CONDITIONS\n\u0003\nPROSTHETIC\nprosthetic cardiac valve, pros\nthetic material used for cardiac valve repair\n\u0003\nCYANOTIC CONGENITAL HEART DISEASE\nunre\npaired, completely repaired but with residual\ndefects at the site or adjacent to the site of\nthe prosthetic device\n\u0003\nCARDIAC TRANSPLANT RECIPIENTS WITH VALVULOPATHY\n\u0003\nPREVIOUS ENDOCARDITIS\n\u0003\nPROCEDURES\n\u0003\nORAL\nCAVITY\nmanipulation of gingival or\nperiapical region of teeth, perforation of oral\nmucosa\n\u0003\nRESPIRATORY\nTRACT\ntonsillectomy, adenoi\ndectomy, bronchoscopy with a rigid broncho\nscope, or flexible bronchoscopy if biopsied\n\u0003\nGI/GU TRACT\ngenerally not recommended\n\u0003\nPROPHYLAXIS REGIMENS\ngive one of the following\n30 60minpriortoprocedure:amoxicillin2gPO/IM/\nIV, cefazolin 1 g IV/IM, ceftriaxone 1 g IV/IM, cepha\nlexin 2 g PO, clindamycin 600 mg PO/IM/IV, azithro\nmycin 500 mg PO, clarithromycin 500 mg PO\nAHA Guidelines 2007\n4. PULMONARY RISK OPTIMIZATION\n\u0003\nPREOPERATIVE\nsmoking\ncessation\nfor\n>8\nweeks. Manage obstructive lung diseases (ipra\ntropium 0.25 mg INH QID for all COPD patients,\nsalbutamol 2.5 mg INH q4h PRN for all COPD/\nasthma patients with wheezing, and steroids if\nexacerbations). Antibiotics and delay surgery if\nrespiratory infection is present. Patient educa\ntion regarding lung expansion maneuvers\n\u0003\nINTRA-OPERATIVE\nlimit duration of surgery to\n<3 h. Avoid general anesthetics (use spinal or\nepidural\nanesthesia).\nAvoid\npancuronium.\nLaparoscopic procedures when possible. Sub\nstitute less ambitious procedure for upper\nabdominal or thoracic surgery when possible\n\u0003\nPOSTOPERATIVE\ndeep breathing exercises or\nincentive spirometry. CPAP if needed. Pain\ncontrol (consider epidural analgesia or intercos\ntal nerve blocks)\n5. MEDICATION MANAGEMENT\n\u0003\nCARDIOVASCULAR\nAGENTS\nb blockers (continue\nup to and including day of surgery. If prolonged\nNPO, substitute with IV labetalol, propanolol,\nmetoprolol, or esmolol). a Agonists (continue\nup to and including day of surgery. If prolonged\nNPO, substitute with TD clonidine or IV methyl\ndopa). Calcium channel blockers (continue up to\nand including day of surgery. If prolonged NPO,\nno IV substitute unless poor hemodynamics). ACE\nINVESTIGATIONS FOR PERIOPERATIVE PATIENTS\n(CONT\u2019D)\nMANAGEMENTOFPERIOPERATIVEPATIENTS(CONT\u2019D)\n424\nPerioperative Assessment for Non-cardiopulmonary Surgery and Postoperative Complications", "text_length": 4817, "metadata": {"source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 430/464)", "type": "chunk", "chunk_index": 429, "total_chunks": 464, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T18:40:09.840481", "document_uuid": "fda2cab4-cdd9-4015-af24-46fd62c86d94", "filename": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf", "category": "medical_pdf", "section": "body", "year": null, "outdated": false, "document_id": "fda2cab4-cdd9-4015-af24-46fd62c86d94"}, "created_at": "2025-12-11T18:40:09.841510", "status": "pending"}